147 related articles for article (PubMed ID: 22202072)
1. The contrasting oncogenic and tumor suppressor roles of FES.
Greer PA; Kanda S; Smithgall TE
Front Biosci (Schol Ed); 2012 Jan; 4(2):489-501. PubMed ID: 22202072
[TBL] [Abstract][Full Text] [Related]
2. An identity crisis for fps/fes: oncogene or tumor suppressor?
Sangrar W; Zirgnibl RA; Gao Y; Muller WJ; Jia Z; Greer PA
Cancer Res; 2005 May; 65(9):3518-22. PubMed ID: 15867340
[TBL] [Abstract][Full Text] [Related]
3. Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma.
Olvedy M; Tisserand JC; Luciani F; Boeckx B; Wouters J; Lopez S; Rambow F; Aibar S; Thienpont B; Barra J; Köhler C; Radaelli E; Tartare-Deckert S; Aerts S; Dubreuil P; van den Oord JJ; Lambrechts D; De Sepulveda P; Marine JC
J Clin Invest; 2017 Jun; 127(6):2310-2325. PubMed ID: 28463229
[TBL] [Abstract][Full Text] [Related]
4. Structure and regulation of the c-Fes protein-tyrosine kinase.
Hellwig S; Smithgall TE
Front Biosci (Landmark Ed); 2011 Jun; 16(8):3146-55. PubMed ID: 21622225
[TBL] [Abstract][Full Text] [Related]
5. Malignant transformation of a human fibroblast cell strain by transfection of a v-fes oncogene but not by transfection of a gag-human c-fes construct.
Lin C; Wang Q; Maher VM; McCormick JJ
Cell Growth Differ; 1994 Dec; 5(12):1381-7. PubMed ID: 7696187
[TBL] [Abstract][Full Text] [Related]
6. A growth-suppressive function for the c-fes protein-tyrosine kinase in colorectal cancer.
Delfino FJ; Stevenson H; Smithgall TE
J Biol Chem; 2006 Mar; 281(13):8829-35. PubMed ID: 16455651
[TBL] [Abstract][Full Text] [Related]
7. Bimolecular fluorescence complementation demonstrates that the c-Fes protein-tyrosine kinase forms constitutive oligomers in living cells.
Shaffer JM; Hellwig S; Smithgall TE
Biochemistry; 2009 Jun; 48(22):4780-8. PubMed ID: 19382747
[TBL] [Abstract][Full Text] [Related]
8. Fes tyrosine kinase expression in the tumor niche correlates with enhanced tumor growth, angiogenesis, circulating tumor cells, metastasis, and infiltrating macrophages.
Zhang S; Chitu V; Stanley ER; Elliott BE; Greer PA
Cancer Res; 2011 Feb; 71(4):1465-73. PubMed ID: 21159660
[TBL] [Abstract][Full Text] [Related]
9. Myeloid expression of the human c-fps/fes proto-oncogene in transgenic mice.
Greer P; Maltby V; Rossant J; Bernstein A; Pawson T
Mol Cell Biol; 1990 Jun; 10(6):2521-7. PubMed ID: 2188092
[TBL] [Abstract][Full Text] [Related]
10. Promoter methylation blocks FES protein-tyrosine kinase gene expression in colorectal cancer.
Shaffer JM; Smithgall TE
Genes Chromosomes Cancer; 2009 Mar; 48(3):272-84. PubMed ID: 19051325
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of a panel of monoclonal antibodies against the catalytic domain of the human fes proto-oncogene product.
van Bokhoven A; van Duijnhoven HL; Jücker M; Roebroek AJ; van de Ven WJ
Mol Biol Rep; 1992 Feb; 16(1):17-25. PubMed ID: 1545781
[TBL] [Abstract][Full Text] [Related]
12. A minimal c-fes cassette directs myeloid-specific expression in transgenic mice.
Heydemann A; Warming S; Clendenin C; Sigrist K; Hjorth JP; Simon MC
Blood; 2000 Nov; 96(9):3040-8. PubMed ID: 11049982
[TBL] [Abstract][Full Text] [Related]
13. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
Rogers JA; Cheng HY; Smithgall TE
Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
[TBL] [Abstract][Full Text] [Related]
14. Structure of the feline c-fes/fps proto-oncogene: genesis of a retroviral oncogene.
Roebroek AJ; Schalken JA; Onnekink C; Bloemers HP; Van de Ven WJ
J Virol; 1987 Jun; 61(6):2009-16. PubMed ID: 3553615
[TBL] [Abstract][Full Text] [Related]
15. fps/fes knockout mice display a lactation defect and the fps/fes tyrosine kinase is a component of E-cadherin-based adherens junctions in breast epithelial cells during lactation.
Truesdell PF; Zirngibl RA; Francis S; Sangrar W; Greer PA
Exp Cell Res; 2009 Oct; 315(17):2929-40. PubMed ID: 19732771
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the c-fes proto-oncogene product with the interleukin-4 receptor.
Izuhara K; Feldman RA; Greer P; Harada N
J Biol Chem; 1994 Jul; 269(28):18623-9. PubMed ID: 7518439
[TBL] [Abstract][Full Text] [Related]
17. Isolation and propagation of yolk-sac-derived endothelial cells from a hypervascular transgenic mouse expressing a gain-of-function fps/fes proto-oncogene.
Wang SJ; Greer P; Auerbach R
In Vitro Cell Dev Biol Anim; 1996 May; 32(5):292-9. PubMed ID: 8792159
[TBL] [Abstract][Full Text] [Related]
18. FES kinase participates in KIT-ligand induced chemotaxis.
Voisset E; Lopez S; Chaix A; Vita M; George C; Dubreuil P; De Sepulveda P
Biochem Biophys Res Commun; 2010 Feb; 393(1):174-8. PubMed ID: 20117079
[TBL] [Abstract][Full Text] [Related]
19. Fps/Fes protein-tyrosine kinase regulates mast cell adhesion and migration downstream of Kit and beta1 integrin receptors.
Smith JA; Samayawardhena LA; Craig AW
Cell Signal; 2010 Mar; 22(3):427-36. PubMed ID: 19892014
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of the c-fes proto-oncogene in adult human myeloid leukemia cells in the absence of gene amplification.
Smithgall TE; Johnston JB; Bustin M; Glazer RI
J Natl Cancer Inst; 1991 Jan; 83(1):42-6. PubMed ID: 1984516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
